Enzymatic reactions control a wide range of normal and pathological cellular conditions. Researchers seek novel ways to measure the biochemical products of enzymatic reactions to gain insight into various diseases and disorders, such as cancer, infection, and aging. Establishing sensitive and specific assays is critical to developing drugs that target the aberrant enzymatic reactions that drive disease.
Download this poster from BellBrook Labs to learn how researchers validated a novel biochemical assay that is applicable to future pharmacological discovery for diseases such as cancer.
